secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2022-08-11T23:59:59+00:00
Accession:  0001193125-22-218522
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q4 revenue $914.7M (+4% YoY); dividend up 5% to $0.44; acquires MEDIFOX DAN for $1B
--------------------------------------------------------------------------------

- Q4 revenue $914.7M (+4% YoY, +8% constant currency); GAAP diluted EPS $1.33.
- Full-year revenue $3.58B (+12% YoY, +13% constant currency); GAAP EPS $5.30.
- Quarterly dividend raised 5% to $0.44/share, payable Sept 22, record Aug 18.
- Announced $1B acquisition of MEDIFOX DAN, a German out-of-hospital software company; expected close by Dec 31, 2022.
- Lucile Blaise promoted to President of Sleep & Respiratory Care effective July 1, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312522218522/0001193125-22-218522-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312522218522/d392713d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-218522

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer